The evidence generated in this study demonstrates that requesting two FSBG values daily and analyzing on average 1.5 daily FSBG results can yield adequate data to guide safe and effective anti-hyperglycemic agent and lifestyle regimen adjustments targeting optimization of blood glucose control in patients with T2DM regardless of their insulin use status. This evidence concerns the gene INS and type 2 diabetes mellitus.